Malaysian Genomics Resource Centre Bhd (XKLS:0155) Cyclically Adjusted Revenue per Share: RM0.12 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:0155 Malaysian Genomics Resource Centre Bhd XKLS:0155
44 GF Score
Price RM0.30
GF Value RM0.31
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Malaysian Genomics Resource Centre Bhd Cyclically Adjusted Revenue per Share?

Malaysian Genomics Resource Centre Bhd XKLS:0155 44 Cyclically Adjusted Revenue per Share is RM0.12 as of Mar. 2026. GuruFocus rates XKLS:0155 with a GF Score™ of 44/100 and a GF Value™ of RM0.31 (Fairly Valued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Malaysian Genomics Resource Centre Bhd's adjusted revenue per share for the three months ended in Mar. 2026 was RM0.018. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is RM0.12 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Malaysian Genomics Resource Centre Bhd's average Cyclically Adjusted Revenue Growth Rate was -7.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 6.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Malaysian Genomics Resource Centre Bhd was 6.30% per year. The lowest was 6.30% per year. And the median was 6.30% per year.

As of today (2026-07-25), Malaysian Genomics Resource Centre Bhd's current stock price is RM0.295. Malaysian Genomics Resource Centre Bhd's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was RM0.12. Malaysian Genomics Resource Centre Bhd's Cyclically Adjusted PS Ratio of today is 2.46.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Malaysian Genomics Resource Centre Bhd was 27.20. The lowest was 1.19. And the median was 3.79.


Malaysian Genomics Resource Centre Bhd  (XKLS:0155) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Malaysian Genomics Resource Centre Bhd's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.295/0.12
=2.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Malaysian Genomics Resource Centre Bhd was 27.20. The lowest was 1.19. And the median was 3.79.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Malaysian Genomics Resource Centre Bhd Cyclically Adjusted Revenue per Share Related Terms


Malaysian Genomics Resource Centre Bhd Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Malaysian Genomics Resource Centre Bhd's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Malaysian Genomics Resource Centre Bhd Cyclically Adjusted Revenue per Share Chart

Malaysian Genomics Resource Centre Bhd Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.10 0.12 0.13 0.12

Malaysian Genomics Resource Centre Bhd Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.12 0.12 0.12 0.12

XKLS:0155 vs TMO, DHR, IDXX: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, Malaysian Genomics Resource Centre Bhd's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Malaysian Genomics Resource Centre Bhd Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Malaysian Genomics Resource Centre Bhd's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Malaysian Genomics Resource Centre Bhd's Cyclically Adjusted PS Ratio falls into.


XKLS:0155
44GF Score
Malaysian Genomics Resource Centre Bhd XKLS:0155
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Malaysian Genomics Resource Centre Bhd Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Malaysian Genomics Resource Centre Bhd's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.018/330.2130*330.2130
=0.018

Current CPI (Mar. 2026) = 330.2130.

Malaysian Genomics Resource Centre Bhd Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201512 0.034 236.525 0.047
201603 0.019 238.132 0.026
201606 0.016 241.018 0.022
201609 0.035 241.428 0.048
201612 0.020 241.432 0.027
201703 0.016 243.801 0.022
201706 0.028 244.955 0.038
201709 0.062 246.819 0.083
201712 0.067 246.524 0.090
201803 0.063 249.554 0.083
201806 0.061 251.989 0.080
201809 0.069 252.439 0.090
201812 0.001 251.233 0.001
201903 0.002 254.202 0.003
201906 -0.002 256.143 -0.003
201909 0.002 256.759 0.003
201912 0.048 256.974 0.062
202003 0.003 258.115 0.004
202006 -0.043 257.797 -0.055
202009 0.001 260.280 0.001
202012 0.001 260.474 0.001
202103 0.016 264.877 0.020
202106 -0.001 271.696 -0.001
202109 0.077 274.310 0.093
202112 0.063 278.802 0.075
202203 0.041 287.504 0.047
202206 0.051 296.311 0.057
202209 0.031 296.808 0.034
202212 0.013 296.797 0.014
202303 0.005 301.836 0.005
202309 0.017 307.789 0.018
202403 0.013 312.332 0.014
202406 0.009 314.175 0.009
202409 0.010 315.301 0.010
202412 0.010 315.605 0.010
202503 0.010 319.799 0.010
202506 0.013 322.561 0.013
202509 0.018 324.800 0.018
202512 0.017 324.054 0.017
202603 0.018 330.213 0.018

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of RM0.12 mean?
Malaysian Genomics Resource Centre Bhd (XKLS:0155) has a Cyclically Adjusted Revenue per Share of RM0.12 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Malaysian Genomics Resource Centre Bhd and its competitors.
Is Malaysian Genomics Resource Centre Bhd's Cyclically Adjusted Revenue per Share too high?
Malaysian Genomics Resource Centre Bhd's current Cyclically Adjusted Revenue per Share is RM0.12. Overall, Malaysian Genomics Resource Centre Bhd has a GF Score™ of 44/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Malaysian Genomics Resource Centre Bhd's Cyclically Adjusted Revenue per Share compare to TMO and DHR?
Malaysian Genomics Resource Centre Bhd's Cyclically Adjusted Revenue per Share of RM0.12 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Malaysian Genomics Resource Centre Bhd and its competitors. Malaysian Genomics Resource Centre Bhd's current Cyclically Adjusted Revenue per Share is RM0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Malaysian Genomics Resource Centre Bhd stock overvalued right now?
Based on GuruFocus' analysis, Malaysian Genomics Resource Centre Bhd (XKLS:0155) is currently considered Fairly Valued. The stock's GF Value™ is RM0.31, compared to a current price of RM0.30 — trading 4.8% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is RM0.12. Malaysian Genomics Resource Centre Bhd's overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Malaysian Genomics Resource Centre Bhd (XKLS:0155), the current Cyclically Adjusted Revenue per Share is RM0.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Malaysian Genomics Resource Centre Bhd (XKLS:0155) Overvalued in 2026?

Based on GuruFocus' analysis, Malaysian Genomics Resource Centre Bhd stock appears to be undervalued. The current stock price of RM0.30 is trading 4.8% below its estimated GF Value™ of RM0.31. GuruFocus considers Malaysian Genomics Resource Centre Bhd to be Fairly Valued.

Key valuation signals for XKLS:0155:

  • Cyclically Adjusted Revenue per Share: RM0.12
  • GF Value™: RM0.31 vs. price of RM0.30 (4.8% below fair value)
  • GF Score™: 44/100 with 3 warning signs

No single metric tells the full story. See the XKLS:0155 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Malaysian Genomics Resource Centre Bhd Business Description

Address Jalan Teknologi 3/6, 8F, Taman Sains Selangor 1, Kota Damansara (PJU5), Petaling Jaya, SGR, MYS, 47810
Malaysian Genomics Resource Centre Bhd is a Malaysia-based company. The company's principal activities include enabling personalized and precision medicine through genetics, genomics, immunotherapy, and biopharmaceutical services, as well as investment holding. It offers genome sequencing and analysis (GSA) services and genetic screening services (GSS). The group offerings include precision genetic screening, project-based analysis, and high-quality cell therapy and cosmeceutical products. The reportable segments of the Group derive their revenue from the provision of personalised and precision medicine through genetics, genomics, immunotherapy, and biopharmaceutical services within the healthcare segment.
44GF Score

Get the complete analysis for XKLS:0155

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.30
Price
RM0.31
GF Value